We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current EDSA market cap is 8.81M. The company's latest EPS is USD -2.6039 and P/E is -1.23.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -2.07M | -2.37M | -1.86M | -2.22M | -1.93M |
| Net Income | -1.99M | -1.72M | -1.68M | -1.86M | -1.67M |
| Year End 30 September 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 411k | 329k | 0 | 0 | 0 |
| Operating Income | -2.83M | -6.4M | -23.68M | -18.37M | -9.22M |
| Net Income | -2.78M | -6.36M | -13.34M | -17.55M | -8.37M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 9.42M | 8.89M | 7.83M | 6.48M | 5.23M |
| Total Liabilities | 1.57M | 1.84M | 1.99M | 2.15M | 2.36M |
| Total Equity | 7.85M | 7.05M | 5.85M | 4.32M | 2.87M |
| Year End 30 September 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 5.72M | 10.76M | 14.58M | 11.58M | 8.89M |
| Total Liabilities | 462k | 4.13M | 1.53M | 2.18M | 1.84M |
| Total Equity | 5.26M | 6.63M | 13.06M | 9.39M | 7.05M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -5.17M | -6.64M | -1.41M | -3.07M | -3.92M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 4.42M | 4.83M | 306k | 518k | 624k |
| Year End 30 September 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -4.85M | -4.99M | -13.66M | -12.28M | -6.64M |
| Investing | 6.42M | 19k | -6k | -5k | N/A |
| Financing | N/A | 7.09M | 14.18M | 11.63M | 4.83M |
| Market Cap | 8.81M |
| Price to Earnings Ratio | -1.23 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 1.92 |
| Price to Book Ratio | 1.46 |
| Dividend Yield | - |
| Shares Outstanding | 3.22M |
| Average Volume (1 week) | 9.48k |
| Average Volume (1 Month) | 13.64k |
| 52 Week Change | -14.91% |
| 52 Week High | 6.46 |
| 52 Week Low | 2.50 |
| Spread (Intraday) | 0.14 (4.95%) |
| Company Name | Edesa Biotech Inc |
| Address |
100 spy court markham, ontario L3R 5H6 |
| Website | https://www.edesabiotech.com/ |
| Industry | business services, nec (7389) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
